|
About the Research Showcase 2023 category
|
|
0
|
622
|
30 March 2023
|
|
Targeting TM6SF2 to Reduce HBV Subviral Particles: A Potential Step Towards a Functional Cure
|
|
4
|
482
|
17 September 2023
|
|
Example entry: Hepatitis B cccDNA viral reservoirs - stubborn nails in the quest for a complete cure
|
|
12
|
369
|
22 August 2023
|
|
The Hepatitis B polymerase: A difficult problem begins to crack
|
|
10
|
835
|
6 July 2023
|
|
Understanding Hepatitis B and Liver Cancer Knowledge and Testing Among Different Communities
|
|
2
|
212
|
30 June 2023
|
|
The EMPOWER-B study – predicting Hepatitis B cure or relapse after treatment cessation
|
|
1
|
210
|
30 June 2023
|
|
Integrated HBV DNA: a hidden contributor to liver cancer and virus persistence?
|
|
4
|
330
|
30 June 2023
|
|
CRISPR-Cas13b: A potential new treatment for HBV
|
|
0
|
179
|
30 June 2023
|
|
Host protein complex shuts down cccDNA: An interesting way of viral suppression
|
|
1
|
195
|
29 June 2023
|
|
Lived experiences of chronic hepatitis B in relation to stigma and discrimination among Chinese immigrants in Australia
|
|
4
|
164
|
22 June 2023
|
|
Physical, Social, and Emotional Impacts of Living with Hepatitis B: Implications for Clinical Care and Drug Development
|
|
5
|
174
|
22 June 2023
|
|
Weaponising Memory Natural Killer Cells, the Unsung Heroes, to Combat Chronic Hepatitis B Infection
|
|
0
|
206
|
20 June 2023
|
|
What prevents you from getting treatment and care? – We want to know!
|
|
3
|
228
|
16 June 2023
|